SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

12 Months Ended

Dec. 31, 2012

Selected Quarterly Financial Data (Unaudited) [Abstract]

Quarterly Financial Information [Text Block]

Note 22. SELECTED QUARTERLY FINANCIAL DATA (UNAUDITED)

Dollars in Millions, except per share data		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Year
2012
Net Sales		$	5,251	$	4,443	$	3,736	$	4,191	$	17,621
Gross Margin			3,948		3,198		2,749		3,116		13,011
Net Earnings/(Loss)			1,482		808		(713)		924		2,501
Net Earnings/(Loss) Attributable to:
	Noncontrolling Interest		381		163		(2)		(1)		541
	BMS		1,101		645		(711)		925		1,960
Earnings/(Loss) per Share - Basic(1)		$	0.65	$	0.38	$	(0.43)	$	0.56	$	1.17
Earnings/(Loss) per Share - Diluted(1)		$	0.64	$	0.38	$	(0.43)	$	0.56	$	1.16
Cash dividends declared per common share		$	0.34	$	0.34	$	0.34	$	0.35	$	1.37
Cash and cash equivalents		$	2,307	$	2,801	$	1,503	$	1,656	$	1,656
Marketable securities(2)			6,307		5,968		5,125		4,696		4,696
Total Assets			32,408		31,667		36,044		35,897		35,897
Long-term debt(3)			5,270		5,209		7,227		7,232		7,232
Equity			16,246		15,812		13,900		13,638		13,638
Dollars in Millions, except per share data		First Quarter		Second Quarter		Third Quarter		Fourth Quarter		Year
2011
Net Sales		$	5,011	$	5,434	$	5,345	$	5,454	$	21,244
Gross Margin			3,668		3,953		3,938		4,087		15,646
Net Earnings			1,367		1,307		1,355		1,231		5,260
Net Earnings Attributable to:
	Noncontrolling Interest		381		405		386		379		1,551
	BMS		986		902		969		852		3,709
Earnings per Share - Basic(1)		$	0.58	$	0.53	$	0.57	$	0.50	$	2.18
Earnings per Share - Diluted(1)		$	0.57	$	0.52	$	0.56	$	0.50	$	2.16
Cash dividends declared per common share		$	0.33	$	0.33	$	0.33	$	0.34	$	1.33
Cash and cash equivalents		$	3,405	$	3,665	$	4,471	$	5,776	$	5,776
Marketable securities(2)			6,453		6,739		6,541		5,866		5,866
Total Assets			30,851		31,833		32,014		32,970		32,970
Long-term debt			5,276		5,332		5,437		5,376		5,376
Equity			15,901		16,145		16,436		15,867		15,867

• Earnings per share for the quarters may not add to the amounts for the year, as each period is computed on a discrete basis.
• Marketable securities includes current and non-current assets.
• Also includes the current portion of long-term debt.

The following specified items affected the comparability of results in 2012 and 2011:

2012
	First		Second		Third		Fourth
Dollars in Millions	Quarter		Quarter		Quarter		Quarter		Year
Accelerated depreciation, asset impairment and other shutdown costs	$	-	$	147	$	-	$	-	$	147
Amortization of acquired Amylin intangible assets		-		-		91		138		229
Amortization of Amylin collaboration proceeds		-		-		(46)		(68)		(114)
Amortization of Amylin inventory adjustment		-		-		9		14		23
Stock compensation from accelerated vesting of Amylin awards		-		-		94		-		94
Process standardization implementation costs		8		5		3		2		18
Upfront, milestone and other licensing payments		-		-		21		16		37
IPRD impairment		58		45		-		39		142
Impairment charge for BMS-986094 intangible asset		-		-		1,830		-		1,830
Provision for restructuring		22		20		29		103		174
Pension curtailments and settlements		-		-		-		151		151
Gain on sale of product lines, businesses and assets		-		-		-		(51)		(51)
Litigation charges/(recoveries)		(172)		22		50		55		(45)
Acquisition-related expenses		12		1		29		1		43
Out-licensed intangible asset impairment		38		-		-		-		38
Loss on debt repurchases		19		-		8		-		27
Total		(15)		240		2,118		400		2,743
Income tax/(tax benefit) on items above		8		(77)		(722)		(156)		(947)
Specified tax benefit*		-		-		-		(392)		(392)
(Increase)/Decrease to Net Earnings	$	(7)	$	163	$	1,396	$	(148)	$	1,404
2011
	First		Second		Third		Fourth
Dollars in Millions	Quarter		Quarter		Quarter		Quarter		Year
Accelerated depreciation, asset impairment and other shutdown costs	$	23	$	18	$	19	$	15	$	75
Pension curtailments and settlements		-		-		-		13		13
Process standardization implementation costs		4		10		5		10		29
Provision for restructuring		44		40		8		24		116
Litigation charges/(recoveries)		(76)		-		10		75		9
Gain on sale of product lines, businesses and assets		-		-		(12)		-		(12)
Upfront, milestone and other licensing payments/(receipts)		88		50		69		(20)		187
IPRD impairment		15		-		13		-		28
Total		98		118		112		117		445
Income tax benefit on items above		(28)		(34)		(37)		(37)		(136)
Specified tax benefit*		(56)		(15)		-		(26)		(97)
Decrease to Net Earnings	$	14	$	69	$	75	$	54	$	212